The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
90627126 9062712 6 F 20110705 20160915 20130213 20160927 EXP US-BAYER-2013-017116 BAYER 57.00 YR A M Y 0.00000 20160927 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
90627126 9062712 1 PS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 400 MG, UNK D 21085 400 MG FILM-COATED TABLET
90627126 9062712 2 SS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 D 21085 FILM-COATED TABLET
90627126 9062712 3 C OXYCODONE W/PARACETAMOL ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 0
90627126 9062712 4 C AMOXICILLIN. AMOXICILLIN 1 0
90627126 9062712 5 C HYDROCODONE HYDROCODONE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
90627126 9062712 1 Influenza like illness
90627126 9062712 2 Bacterial infection

Outcome of event

Event ID CASEID OUTC COD
90627126 9062712 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
90627126 9062712 Anhedonia
90627126 9062712 Anterior chamber inflammation
90627126 9062712 Blindness
90627126 9062712 Ciliary body disorder
90627126 9062712 Deposit eye
90627126 9062712 Drug prescribing error
90627126 9062712 Emotional distress
90627126 9062712 Eye degenerative disorder
90627126 9062712 Eye injury
90627126 9062712 Eye pain
90627126 9062712 Eye swelling
90627126 9062712 Glaucoma
90627126 9062712 Injury
90627126 9062712 Intraocular pressure increased
90627126 9062712 Iridocyclitis
90627126 9062712 Iris disorder
90627126 9062712 Iris hypopigmentation
90627126 9062712 Iris transillumination defect
90627126 9062712 Medication error
90627126 9062712 Ocular hyperaemia
90627126 9062712 Ophthalmoplegia
90627126 9062712 Pain
90627126 9062712 Photophobia
90627126 9062712 Pigment dispersion syndrome
90627126 9062712 Product use issue
90627126 9062712 Quality of life decreased
90627126 9062712 Uveitis
90627126 9062712 Vision blurred
90627126 9062712 Visual acuity reduced
90627126 9062712 Visual impairment
90627126 9062712 Vitreous floaters
90627126 9062712 Vitritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
90627126 9062712 1 20110705 20110707 0